Ioannis Parodis

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (16)

Pier Paolo Sainaghi

Professore Associato in Medicina Interna

Università degli Studi del Piemonte Orientale

ITALY

View details

John D. Pauling

UNITED KINGDOM

View details

Silvia Aguilera

EPFL (École Polytechnique Fédérale de Lausanne)

SWITZERLAND

View details

Anthony Redmond

Professor of Clinical Biomechanics

University of Leeds

UNITED KINGDOM

View details

Nilesh Srivastav

Lecturer

Melbourne Institute, University of Melbourne

AUSTRALIA

View details

João Eurico Fonseca

PORTUGAL

View details

Tanja Stamm

Medical University of Vienna

AUSTRIA

View details

Hans-Joachim Anders

GERMANY

View details

Brad H Rovin

The Ohio State University Wexner Medical Center

UNITED STATES

View details

Laura ANDREOLI

University of Brescia

ITALY

View details

Denis Lagutkin

Karolinska Institutet

SWEDEN

View details

Andreas Schwarting

Head, Division of Rheumatology and Clinical Immunology, Prof.Dr.

University Medical Center of the Johannes Gutenberg University Mainz

GERMANY

View details

Elisabet Welin

professor

Örebro university

SWEDEN

View details

Alvaro Gomez

Karolinska Institutet

SWEDEN

View details

Yvonne Enman

Karolinska Institutet

SWEDEN

View details

Christopher Sjöwall

Senior Associate Professor

Linköping University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ioannis Parodis

Research Interests

Explore related searches

Contact this professor

Articles (30)

Lupus nephritis

New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity–could anti-LIN28A enhance precision in diagnostics?

Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1

Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosus.

Unsupervised machine learning identifies distinct SLE patient endotypes with differential response to belimumab

Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus.

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus.

Belimumab efficacy in mucocutaneous manifestations of systemic lupus erythematosus: a large post hoc analysis of five phase III clinical trials

Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey

Updating the OMERACT Systemic Lupus Erythematosus Core Outcome Set

Response to Comment on “Effect of Belimumab on Preventing De Novo Renal Lupus Flares”

Immune Mechanisms and Biomarkers in Systemic Lupus Erythematosus

Patients with NPSLE experience poorer HRQoL and more fatigue than SLE patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity

Belimumab concentration measurements using a homologous anti-idiotype immunoassay.

Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials.

Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study.

Neuropsychiatric involvement in systemic lupus erythematosus contributes to organ damage beyond the nervous system: a post-hoc analysis of 5 phase III randomized clinical trials

Cardiovascular Risk Evaluation in Psoriatic Arthritis by Aortic Stiffness and the Systemic Coronary Risk Evaluation (SCORE): Results of the Prospective PSOCARD Cohort Study.

OMERACT systemic lupus erythematosus domain survey.

Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD dataset.

Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey.

Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey

Intracardiac Thrombi in Morbus Adamantiades–Behçet in Two Swedish Patients

Systematic literature review informing the EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study

EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials

Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab

Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State

COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis.

Collaborators (16)

Pier Paolo Sainaghi

John D. Pauling

Silvia Aguilera

Anthony Redmond

Nilesh Srivastav

João Eurico Fonseca

Tanja Stamm

Hans-Joachim Anders

Brad H Rovin

Laura ANDREOLI

Denis Lagutkin

Andreas Schwarting

Elisabet Welin

Alvaro Gomez

Yvonne Enman

Christopher Sjöwall

Make your next move.